Neuralstem (CUR - Get Report) is focused on developing and commercializing of treatments for central nervous system disease based on transplanting human neural stem cells and small molecule drugs. This stock closed up 12% to $1.28 in recent trading.
Thursday's Range: $1.22-$1.3352-Week Range: $0.42-$1.96 Volume: 4.5 million Three-Month Average Volume: 1.2 million >>5 Stocks Insiders Love Right Now From a technical perspective, CUR is gapped up sharply higher here with above-average volume. This move followed some buying interest the prior day that came in right near its 200-day moving average of 99 cents. Shares of CUR are now pushing within range of triggering a major breakout trade. That trade will hit once CUR manages to clear some near-term overhead resistance levels at $1.38 to $1.55 with high volume. Traders should now look for long-biased trades in CUR as long as it's trending above some near-term support at $1.20, and then once it sustains a move or close above those breakout levels with volume that hits near or above 1.2 million shares. If that breakout triggers soon, then look for CUR to re-test or possibly take out its next major overhead resistance level at $1.96 to $2.03. Any high-volume move above those levels could send this stock higher towards to $2.70 to $3 in the near future.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts